MLYS — Mineralys Therapeutics Share News
0.000.00%
Last trade - 00:00Mineralys Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Mineralys Therapeutics Inc expected to post a loss of 98 cents a share - Earnings Preview
Mineralys Therapeutics Inc expected to post a loss of 98 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
U.S. STOCKS ON THE MOVE-Corvus, Dogwood Therapeutics, Uranium Energy
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
Mineralys drops as $175 mln stock offering priced
Brief: Mineralys Therapeutics Announces Pricing Of $175.0 Million Underwritten Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
U.S. STOCKS ON THE MOVE-BankUnited, Hesai Group, Sezzle
Mineralys launches $250 mln equity offering to fund blood pressure drug; shares dip
Mineralys hits near two-year high as blood pressure drug meets trial goals
U.S. STOCKS ON THE MOVE-Veren, CME Group, Cognizant
U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group
Mineralys' drug for persistent hypertension succeeds in two trials (updated)
U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, Redfin
Mineralys surges as blood pressure drug meets trial goals
Mineralys Therapeutics' blood pressure drug meets goal in trials (updated)